InvestorsHub Logo

The Lawman

03/01/17 11:20 PM

#11695 RE: BlackDoggie #11694

BD:

As with most clinical stage biopharma stocks, it's all about the data.

If we get good data, the sp will go up.

If we get bad data, the sp will crater.

Everything else is just noise.

LM